Advanced Search

Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2009 December;100(6) > Minerva Medica 2009 December;100(6):525-34



A Journal on Internal Medicine

Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,236

Frequency: Bi-Monthly

ISSN 0026-4806

Online ISSN 1827-1669


Minerva Medica 2009 December;100(6):525-34


GA2LEN (Global Allergy and Asthma European Network): European network of excellence for asthma and allergic diseases

Gjomarkaj M. 1, Pace E. 1, Canonica G. W. 2, Bonini S. 3, Ricci G. 4, Burney P. 5, Zuberbier T. 6, Van Cauwenberge P. 7, Bousquet J. 8

1 Consiglio Nazionale delle Ricerche-Istituto di Biomedicina ed Immunologia Molecolare Palermo, Italia
2 Clinica di Malattie dell'Apparato Respiratorio Università di Genova, Italia
3 Seconda Università di Napoli, INMM-CNR, Roma, Italia
4 Dipartimento di Pediatria, Università di Bologna, Italia
5 Istituto Nazionale per il le malattie cardiache e polmonari, Imperial College, Epidemiologia e Salute Pubblica, Londra, Gran Bretagna
6 Centro di studi per le malattie allergiche Charité Università di Berlino, Berlino, Germania
7 Università di Ghent, Ghent, Belgio
8 Ospedale Arnaud de Villeneuve, INSERM U780, Montpellier, France

Allergic diseases represent some of the main health problems in Europe. These are increasing in prevalence, seriousness and social cost. The Global Allergy and Asthma European Network (GA2LEN), a network of excellence of the 6° management program, was created in the 2005 with the aim to gather the European leader institutions of the research and clinical assistance fields, in order to guarantee the excellence and avoid the fragmentation of the energy spent in fighting allergy diseases in general. The GA2LEN has drawn a great advantage from the personal efforts of every single researcher who have proved their strong motivation in carrying on this “pan-European” model of collaboration. The network has been organized in order to increase the team work in scientific research projects in allergic and asthma disease field, making the GA2LEN the worldwide leader in this area. On these basis research projects have been carried on about which first data have been already published. The activities of the GA2LEN include in general the establishment of a lasting organization of the planning phase, the activity linked to every single project and to the improving on the existing projects, as well as the draft of new guidelines. This review reports the main achieved goals.

language: Italian


top of page